[News] Dr. Jung-mok Jo Recognized for Clinical Expertise Through Selection as a Motiva Korea KCE!

Dr. Jung-mok Jo Selected as a Motiva Korea KCE

Evaluation of Expertise in Operating Patient-Specific Breast Augmentation Clinical Application Standards

Being recognized for

outstanding clinical expertise in the field of breast augmentation

is highly meaningful for a medical professional.

We are pleased to share the news that

Dr. Jung-mok Jo of Eton

has been selected as a KCE (Key Clinic Expert),

operated by Motiva Korea,

the Korean corporation of the global breast implant brand “Motiva.”

This means that his

depth of clinical experience built in the field of breast augmentation

and ability to provide patient-specific care

have been officially recognized!

The Motiva KCE program

is an expert program granted only to medical professionals

who have systematically operated

surgical application standards and

clinical decision-making systems based on

clinical experience accumulated in actual practice.

In particular, whether a clinic has

accumulated diverse clinical application experience

and established consistent treatment standards

is reflected as a key selection criterion.

This gives us an idea of just how outstanding

Dr. Jung-mok Jo of Eton’s expertise is!

Motiva Korea also explained:

“Based on diverse clinical cases in the field of breast augmentation,

Dr. Jung-mok Jo has established application standards suited to

each patient’s physical characteristics and surgical goals,”

and added,

“We highly evaluated his clinical decision-making experience

accumulated in actual treatment settings

and his ability to operate stable clinical care.”

Dr. Jung-mok Jo’s selection as a KCE

will provide opportunities to participate in

academic society and scholarly exchange activities,

sharing clinical cases accumulated at the clinic

and surgical application experience.

Through this, discussions on

clinical care standards and surgical decision-making processes

in actual clinical settings

are expected to become more active.

Dr. Jung-mok Jo stated that

breast augmentation surgery

is a process that requires careful decision-making

by comprehensively considering

the patient’s physical characteristics and surgical goals,

and expressed his intention

to share more rational application standards

and directions for clinical care

with other medical professionals

based on the experience

he has accumulated in clinical practice.

Recently, in the field of breast augmentation,

beyond an approach focused simply on outcomes,

the importance of surgical decision-making

that considers application standards in actual clinical settings

and long-term safety

has been increasingly emphasized.

Many people carefully consider these factors

when choosing a plastic surgery clinic.

The trend toward expanding academic exchange,

where medical professionals share clinical experience

and treatment standards,

is expected to bring patients

safer and more satisfactory results.

Dr. Jung-mok Jo’s selection as a KCE

is very positive news in this context,

and we hope that he will continue to contribute

to the development of breast augmentation

through patient-centered care

and active academic activities.